SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-05 |
| Reported value | $65,558,755 |
| Positions | 1 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | RXRX | CL A | $65,558,755 | 13,434,171 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.